Skip to content
Review Open access

Overall treatment time and oncologic outcomes after definitive radiotherapy or chemoradiotherapy for cervical cancer: a systematic review and meta-analysis

Oct 2026 · Frontiers in Oncology · Vol 16 · 0 citations · 47 references
Medicine

TL;DR

Findings support timely completion of definitive radiotherapy and indicate that the 56-day interval remains a clinically relevant benchmark for cervical cancer.

Abstract

Background Prolonged overall treatment time (OTT) during definitive radiotherapy has long been considered detrimental in cervical cancer, but the magnitude and consistency of its prognostic association across treatment eras remain uncertain. We evaluated the association between OTT and oncologic outcomes after definitive radiotherapy or chemoradiotherapy. Methods PubMed/MEDLINE, Embase, Web of Science Core Collection, Scopus, and the Cochrane Library were searched from inception through August 1, 2026. Eligible studies assessed OTT from initiation of external-beam radiotherapy through completion of the planned definitive radiotherapy course as either a categorical or continuous prognostic factor. Risk of bias was assessed using the Quality In Prognosis Studies tool. Time-to-event estimates were pooled as hazard ratios (HRs) with 95% confidence intervals (CIs) using random-effects models. Results Nineteen studies comprising 15,859 patients were included. Ten independent cohorts contributed to the primary overall survival (OS) analysis. Prolonged OTT was associated with poorer OS (HR, 1.61; 95% CI, 1.30–1.99; I² = 76%). In the prespecified analysis of three independent cohorts comparing OTT >56 versus ≤56 days, the association persisted (HR, 1.16; 95% CI, 1.04–1.31; I² = 37%). Prolonged OTT was also associated with a higher risk of local/pelvic/in-field failure (HR, 1.80; 95% CI, 1.26–2.56; I² = 46%). The OS association was consistent across treatment-era and cutoff-source subgroups and remained robust in sensitivity analyses. Conclusion Prolonged OTT is associated with poorer survival and a higher risk of local/pelvic/in-field failure after definitive radiotherapy or chemoradiotherapy for cervical cancer. These findings support timely completion of definitive radiotherapy and indicate that the 56-day interval remains a clinically relevant benchmark. Systematic review registration https://www.crd.york.ac.uk/PROSPERO/view/CRD420261470588, identifier CRD420261470588.

Read PDF

Similar papers

Review Oct 2026

Chemoradiotherapy versus radiotherapy as adjuvant treatment for head and neck adenoid cystic carcinoma: a meta-analysis.

OBJECTIVES The benefit of adding chemotherapy to postoperative radiotherapy for head and neck adenoid cystic carcinoma (ACC) remains uncertain. We compared adjuvant chemoradiotherapy (CRT) with radiotherapy (RT) alone. METHODS PubMed, Embase, and Scopus were searched from inception through May 6, 2026, with manual re...

Ting-Chia Young, Wing-Keen Yap, Kai-Ping Chang et al. · 0 citations
Review Open access Sep 2026

Efficacy and cosmetic outcomes of radiotherapy modalities in early-stage breast cancer: a systematic review and network meta-analysis

Among patients with early-stage BC, HF-WBI was associated with the lowest rate of postoperative ipsilateral recurrence, whereas CF-WBI was associated with the second-lowest rate, and 3D-CRT and IMRT demonstrated favorable clinical efficacy and cosmetic outcomes.

Yu-Shan Dong, Ting-Ting Liu, Peng Wang et al. · 0 citations
Review Open access Oct 2026

Focal therapy vs radical prostatectomy for localized prostate cancer: a systematic review, meta-analysis, bayesian network, and trial sequential analysis.

BACKGROUND Prostate cancer is a prevalent malignancy with procedural treatment strategies. These treatments are associated with significant quality of life impact, including erectile dysfunction and urinary incontinence. Focal therapy (FT) has emerged as an option that may minimize treatment-related side effects. Its e...

D. Hinojosa-Gonzalez, Bailey R. Slawin, M. Torres-Martinez et al. · 0 citations
Review Open access Oct 2026

Predicting outcomes in locally advanced cervical cancer treated with radiotherapy: a systematic review of nomograms

To systematically evaluate published nomograms developed for patients with locally advanced cervical cancer (LACC) treated with radiotherapy, focusing on prognostic performance, core predictive variables, and implications for future model development. A systematic literature search of PubMed, Embase, Scopus,...

Jaekyung Bae, U. Kim, Sokbom Kang · 0 citations
Review Open access Oct 2026

Survival Benefits and Treatment-Related Toxicities of Definitive Concurrent Chemoradiotherapy: A Systematic Review of Randomized Controlled Trials

Background: Definitive concurrent chemoradiotherapy (CRT) is a standard-of-care treatment for multiple locally advanced solid malignancies, including head and neck, cervical, esophageal, and non-small cell lung cancers. While randomized controlled trials (RCTs) consistently demonstrate improved survival with CRT compar...

Jamal Uddin, Harun Or Roshid, Sujan Mahamud et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.